Author:
Chander Vikas,Gangenahalli Gurudutta
Abstract
AbstractPlatelet microvesicles (pMVs) are submicron-sized heterogeneous vesicles released upon activation and contain several membrane receptors and proteins (CD41, CD61, CD62, CXCR4, PAR-1, etc.). We have revealed their ability to adhere to the triblock copolymer pluronic-F127 (PF127) and form a platelet microvesicular nanocloud which has the potential to enhance the transvascular migration of hematopoietic stem cells across the sinusoidal endothelium to the bone marrow. Besides, the pMVs nanoclouds bestow survival benefits when present on the cells used for infusion, particularly with PF127-stabilized with chitosan-alginate (PF127-CA HSCs). The vesicles were found to be firmly associated with PF127 in the nanocloud, which was detected by confocal laser scanning microscopy. The abrogation of CXCR4/SDF-1 axis regulating the transmigration of the cells by antagonist AMD3100 revealed that the enriched CXCR4 receptors on pMVs robustize the transmigration of the infused cells. The homing of the cells led to effective engraftment and faster regeneration of the critical blood lineages, which elicited 100% survival of the mice receiving lethal doses of radiation. The Human Long-Term Culture Initiating Cells (LTC-ICs), Severe Combined Immunodeficient (SCID) - Repopulating Cells (SRCs) and Colony Forming Cells (CFCs) responsible for the regeneration, but present in extremely low numbers in the infused cell dose, have enabled the cells to reach the bone marrow in high numbers. This potential of the PF127 to sequester the pMVs and its application to achieve over 10-fold delivery of HSCs across the trans-endothelial checkpoint has so far not been reported. Thus, this mechanistic innovation is a potential post-exposure life-saving regimen capable of circumventing the irreparable damage to the bone marrow caused by lethal doses of radiation.
Funder
DRDO | Institute of Nuclear Medicine and Allied Sciences, Defence Research and Development Organisation
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Bodratti, A. M. & Alexandridis, P. Formulation of Poloxamers for Drug Delivery. J. Funct. Biomater. 18, 1–24 (2018).
2. Devi, D. R., Sandhya, P. & Vedha Hari, B. N. oloxamer: A Novel Functional Molecule for Drug Delivery and Gene Therapy. J. Pharm. Sci. & Res. 5, 159–165 (2013).
3. Amiji, M. & Park, K. Prevention of protein adsorption and platelet adhesion on surfaces by PEO/PPO/PEO triblock copolymers. Biomaterials. 13, 682–692 (1992).
4. Ahmed, F., Alexandridis, P., Shankaran, H. & Neelamegham, S. The ability of poloxamers to inhibit platelet aggregation depends on their physicochemical properties. Thromb. Haemost. 86, 1532–1539 (2001).
5. Pitto-Barry, A. & P E Barry, N. Pluronic block-copolymers in medicine: from chemical and biological versatility to rationalization and clinical advances. Polym. Chem. 5, 3291–3297 (2014).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献